Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generation of evidence to support the drug’s value proposition. In the last few years, the industry has moved away from a one-size-fits-all go-to-market strategy (predominantly based on physical channels) and adopted a more digital approach using artificial intelligence (AI)/machine learning/cloud-based software and implementing predictive analytics and other Software-as-a-Service (SaaS)-based solutions. Commercial solution providers that incorporate payer landscape intelligence, industry access messaging, and outcomes-linked content frameworks into their platforms will deliver differentiated value beyond traditional healthcare provider engagement. Omnichannel marketing, programmatic advertising, and other routes that enlist influencers, social media, and digital devices are part of the industry’s digital transformation.

The main goal is continuous improvement.

• What role do AI, machine learning, cloud-based software, predictive analytics, and SaaS-based solutions play in transforming pharmaceutical commercialization?
• How are commercial solution providers using payer intelligence, industry access messaging, and outcomes-focused content to deliver differentiated value and strengthen competitive positioning?
• What are the major companies benchmarked in this Frost Radar™, and how can you adopt industry best practices and gain a competitive edge over them?